Cargando…
Hyperglycemia triggers HIPK2 protein degradation
Homeodomain interacting protein kinase-2 (HIPK2) is an evolutionary conserved kinase that modulates several key molecular pathways to restrain tumor growth and induce p53-depending apoptotic cell-death in response to anticancer therapies. HIPK2 silencing in cancer cells leads to chemoresistance and...
Autores principales: | Baldari, Silvia, Garufi, Alessia, Granato, Marisa, Cuomo, Laura, Pistritto, Giuseppa, Cirone, Mara, D'Orazi, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352047/ https://www.ncbi.nlm.nih.gov/pubmed/27901482 http://dx.doi.org/10.18632/oncotarget.13595 |
Ejemplares similares
-
The Sweet Side of HIPK2
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
por: Garufi, Alessia, et al.
Publicado: (2023) -
HIPK2 as a Novel Regulator of Fibrosis
por: Garufi, Alessia, et al.
Publicado: (2023) -
p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions
por: Garufi, Alessia, et al.
Publicado: (2017) -
Targeting COX-2/PGE(2) Pathway in HIPK2 Knockdown Cancer Cells: Impact on Dendritic Cell Maturation
por: Garufi, Alessia, et al.
Publicado: (2012)